Quidel Receives PMDA Approval for Its Point-of-Care Sofia Influenza A+B Assay

Quidel Receives PMDA Approval for Its Point-of-Care Sofia Influenza A+B Assay


Sofia is the brand name for Quidel's instrumented immunoassay system. The easy-to-use Sofia Analyzer and Sofia Influenza A+B FIA combine unique software and fluorescent chemistry to yield an automatic, objective result that is readily available on the instrument's screen, in a hard-copy printout, and in a transmissible electronic form that can network via an LIS system to hospital and medical center databases.



from Biotech News